Michelle Jones London, Ph.D.

Job Title
Photo of Michelle D. Jones-London, PhD
Office of Programs to Enhance Neuroscience Workforce Diversity
Division of Extramural Activities
Areas of Interest

Workforce Diversity

Contact Email
Contact Number

Dr. Michelle D. Jones-London serves as Chief, Office of Programs to Enhance Neuroscience Workforce Diversity (OPEN-WD). In this position, she plays a critical role in guiding the Institute’s diversity efforts and chairs the NINDS Diversity Working Group. Dr. Jones-London joined NINDS as a Program Director in July, 2006. Dr. Jones-London earned her Ph.D. in Neuroscience from the Department of Neuroscience and Anatomy at Pennsylvania State University College of Medicine. She then received postdoctoral training as a research fellow at University of Pennsylvania in the Department of Psychiatry. Dr. Jones-London came to the NIH in July 2004 as an Emerging Leader Fellow; she performed duties across the Department of Health and Human Services including the Center for Scientific Review, FDA Office of Women's Health Science Program, and the Immediate Office of the Secretary, Intergovernmental/Tribal Affairs Office. Dr. Jones-London directs the diversity training and workforce development programs at NINDS which include Diversity and Re-Entry Supplements, Predoctoral Fellowships to Promote Diversity in Health-Related Research (F31), Career Development Awards to Promote Diversity (MOSAIC K99/R00 and K01) and Diversity Research Education Grants (R25) (including the Neuroscience Scholars Program with SfN). She also provides oversight for the Institute’s diversity outreach initiatives at several other national scientific conferences. Her trans-NIH efforts include oversight for the NIH Blueprint ENDURE and DSPAN (F99/K00) programs, the BRAIN Initiative Diversity K99/R00, former Project Scientist for the NIH National Research Mentoring Network (NRMN) and part of the leadership team for NIH Faculty Institutional Recruitment for Sustainable Transformation (FIRST). Her research interests have focused on understanding monoaminergic neurotransmitter regulation and mechanisms of behavioral psychopharmacology in animal models of disorders such as ADHD, Tourette Syndrome, and depression.